Susquehanna International Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,600
Closed -$446K 11928
2024
Q2
$446K Sell
19,600
-68,600
-78% -$1.58M ﹤0.01% 8537
2024
Q1
$2.68M Buy
+88,200
New +$2.95M ﹤0.01% 4727
2020
Q4
Sell
-5,700
Closed -$227K 10985
2020
Q3
$227K Buy
5,700
+200
+4% +$8.48K ﹤0.01% 9253
2020
Q2
$247K Sell
5,500
-77,900
-93% -$3.39M ﹤0.01% 8678
2020
Q1
$2.8M Buy
+83,400
New +$3M ﹤0.01% 3403
2019
Q4
Sell
-21,400
Closed -$534K 9682
2019
Q3
$534K Buy
+21,400
New +$611K ﹤0.01% 7148
2019
Q1
Sell
-9,000
Closed -$275K 8788
2018
Q4
$275K Buy
+9,000
New +$280K ﹤0.01% 7157
2017
Q4
Sell
-16,500
Closed -$369K 9212
2017
Q3
$369K Sell
16,500
-800
-5% -$18.1K ﹤0.01% 7047
2017
Q2
$420K Sell
17,300
-15,000
-46% -$319K ﹤0.01% 6963
2017
Q1
$619K Buy
+32,300
New +$566K ﹤0.01% 6099

Other funds holding ATRC

Susquehanna International Group's ATRC Position: Q1 2026 in Review

Susquehanna International Group opened a new position in AtriCure (ATRC) in Q1 2026: 38,777 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #7613 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ATRC as recently as Q2 2025.

Susquehanna International Group first reported a position in ATRC in Q4 2016 and has held it in 22 quarters since. The position peaked at $2.51M in Q1 2020. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Susquehanna International Group held 38,777 shares of AtriCure worth $1.11M as of Q1 2026.
  • AtriCure was a new Susquehanna International Group position in Q1 2026.
  • AtriCure made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #7613 holding.
  • Susquehanna International Group first reported a position in AtriCure in Q4 2016 and has held it in 22 quarters since.
  • Susquehanna International Group's AtriCure position peaked at $2.51M in Q1 2020.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.